Related Experiment Video
Updated: Apr 7, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.3K
Second line therapy in malignant pleural mesothelioma: A systematic review
Wieneke A Buikhuisen1, Birgitta I Hiddinga2, Paul Baas1
1Thoraxoncologie, Nederlands Kanker Instituut, Amsterdam, The Netherlands.
Lung Cancer (Amsterdam, Netherlands)
|July 12, 2015
Abstract
None:
After the implementation of standard first line chemotherapy with platinum and antifolates in pleural mesothelioma, patients are confronted with a need for second line treatment at relapse or progression. We conducted a systematic review of the literature for the activity, effectiveness and toxicity of second line treatment. The results are presented according to the class of drugs: chemotherapy and targeted or biological agent.
Keywords:
BiologicalChemotherapyMesotheliomaMeta-analysisOutcomeSecond lineTargeted treatmentTreatment
